0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

What now for Prevent?

22 June 2017

Recent terrorist atrocities have brought the Government’s Prevent Strategy into sharp focus and pose two important questions – is the strategy fit for purpose and what will be expected of schools to adequately discharge their duty to have “due regard to the need to prevent people from being drawn into terrorism”?

There has long been concern that the prevent strategy focussed the mind – intentionally or otherwise – on the threat of Islamic radicalisation. Given recent events, will this now change? According to the Independent, nearly a third of referrals to Channel and 8% of arrests were based on extreme far right views. Without a shift in focus, I would expect those numbers to climb.

So should we expect a new approach? There has been no suggestion of it yet, but at the very least I expect Ofsted to pay greater attention to the steps schools are taking to discharge their duty and in the longer term we are likely to see new guidance, updated training expectations and an even sharper focus on this issue during inspections.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up